Pediatric Clinical Data

Give your pediatric patients significant allergy relief with Children’s ZYRTEC®1

Studies show powerful symptom responses in ages 2 to 111

ZYRTEC® is generally well tolerated by children1*

In clinical trials in children with seasonal allergic rhinitis (SAR), ZYRTEC® demonstrated:

See how Children’s ZYRTEC® compares with other children’s OTC oral antihistamines

Good taste, guaranteed

Children’s ZYRTEC® is covered by the Kenvue Pediatrics Taste Guarantee.

A story for caregivers to share with kids

Popular 2-part set helps families manage allergies. Available to download in English and Spanish.

Free monthly Bundle Box supports your pediatric patient care

Samples and resources from Children’s ZYRTEC® and other Kenvue Pediatric products.

*Tolerability profile demonstrated in clinical trials of children ages 6 to 11 years.

†Among OTC oral antihistamines.

‡ZYRTEC® is the #1 Pediatrician-recommended brand.

§ZYRTEC® membership program for healthcare professionals is ZYRTEC ZIPLINE®.

References: 1. Data on file. Johnson & Johnson Consumer Inc., McNeil Consumer Health Division. 2. Children’s Allegra® Drug Facts. 3. Children’s Claritin® Oral Solution Drug Facts. 4. Children’s ZYRTEC® Allergy Syrup Drug Facts. 5. Xyzal® Allergy 24HR Oral Solution Drug Facts. 6. Allegra® [package insert]. Bridgewater, NJ: Sanofi-Aventis U.S. LLC; 2007. 7. FAQs. Allegra®. Accessed May 20, 2021.